BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8223992)

  • 1. A case of lipoatrophy with human insulin-therapy.
    Chantelau E; Reuter M; Schotes S; Starke AA
    Exp Clin Endocrinol; 1993; 101(3):194-6. PubMed ID: 8223992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin-induced lipoatrophy--caused by monocomponent insulin?].
    Gyimesi A; Iványi J
    Orv Hetil; 1989 Dec; 130(51):2751-2. PubMed ID: 2689957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human insulin-induced lipoatrophy. Successful treatment using a jet-injection device.
    Logwin S; Conget I; Jansa M; Vidal M; Nicolau C; Gomis R
    Diabetes Care; 1996 Mar; 19(3):255-6. PubMed ID: 8742573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion.
    Meyer L; Hadjadj S; Guerci B; Delbachian I; Ziegler O; Drouin P
    Diabetes Metab; 1998 Dec; 24(6):544-6. PubMed ID: 9932222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of lipoatrophy with insulin detemir.
    Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoatrophy with insulin analogues in type I diabetes.
    Babiker A; Datta V
    Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe lipoatrophy with human insulin: successfully treated by CSII.
    Chantelau E; Reuter M; Schotes S; Starke AA
    Diabet Med; 1993 Jul; 10(6):580-1. PubMed ID: 8365099
    [No Abstract]   [Full Text] [Related]  

  • 8. [Insulin-induced panniculitis].
    Verbenko EV; Kamynina TS; Zlatkina AR; Ezhova MN
    Vestn Dermatol Venerol; 1988; (1):63-6. PubMed ID: 3284233
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus.
    Peteiro-González D; Fernández-Rodríguez B; Cabezas-Agrícola JM; Araújo-Vilar D
    Diabetes Res Clin Pract; 2011 Mar; 91(3):e61-3. PubMed ID: 21146887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human insulin and lipoatrophy.
    Page MD; Bodansky HJ
    Diabet Med; 1992 Oct; 9(8):779. PubMed ID: 1395476
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of insulin lipoatrophy. A case report.
    Asherov J; Mimouni M; Laron Z
    Diabete Metab; 1979 Mar; 5(1):1-3. PubMed ID: 571820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
    Szypowska A; Skórka A; Pańkowska E
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the effects of chromatographically purified insulin TZF-Polfa and highly purified insulin Nordisk on insulin-induced lipoatrophy].
    Leowski J; Tatoń J; Czech A; Laz R
    Pol Tyg Lek; 1987 Dec; 42(50):1577-80. PubMed ID: 3330794
    [No Abstract]   [Full Text] [Related]  

  • 14. Subcutaneous antihistamine injection is effective to control a local allergic reaction to human insulin.
    Imakado S; Hamada K; Atsumi Y
    Diabetes Res Clin Pract; 2009 Sep; 85(3):e42-3. PubMed ID: 19520450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoatrophy is a thing of the past, or is it?
    Hussein SF; Siddique H; Coates P; Green J
    Diabet Med; 2007 Dec; 24(12):1470-2. PubMed ID: 17976201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
    Holstein A; Stege H; Kovacs P
    Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human insulin-induced lipoatrophy].
    Jermendy G; Nádas J; Sápi Z
    Orv Hetil; 2000 Oct; 141(44):2393-6. PubMed ID: 11105557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of lipoatrophy with insulin glargine: long-acting insulin analogs are not exempt from this complication.
    Ampudia-Blasco FJ; Girbes J; Carmena R
    Diabetes Care; 2005 Dec; 28(12):2983. PubMed ID: 16306570
    [No Abstract]   [Full Text] [Related]  

  • 19. Lispro insulin-induced lipoatrophy: a new case.
    Al-Khenaizan S; Al Thubaiti M; Al Alwan I
    Pediatr Diabetes; 2007 Dec; 8(6):393-6. PubMed ID: 18036067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection site lipoatrophy: a rare complication of recombinant human insulin.
    Chakraborty PP; Bhattacharjee R
    J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.